Related Experiment Video
Updated: Feb 11, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
Intraperitoneal treatment in ovarian cancer: the gynecologic oncology group perspective in 2012
Deborah K Armstrong1, Keiichi Fujiwara1, Danijela Jelovac1
1From the Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD.
Abstract:
The peritoneal cavity is the major site of disease in ovarian cancer. The peritoneal predominance of disease provides a rationale for administration of chemotherapy within the peritoneal cavity. Intraperitoneal (IP) chemotherapy for ovarian cancer has been studied rigorously for more than 30 years and has been reproducibly shown to improve the survival of patients with ovarian cancer. Three large randomized trials of IP compared with intravenous (IV) therapy have demonstrated statistically significant improvement in clinical outcome measures. Despite this, the IP approach has not gained widespread acceptance in the treatment of ovarian cancer. Here, we review reported, recently completed, and ongoing trials of IP therapy in ovarian cancer including attempts to improve the tolerability and acceptance of this proven approach.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Social Cognitive Perspective on Personality
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...
The Behavioral Perspective on Personality
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

